FuturaGene
Biotechnology Research • 
Rehovot, Center District, Israel • 51-100 Employees
Company overview
| Headquarters | 4th Floor, 2 Pekeris Street, Rehovoth, IL |
| Website | |
| SIC | 873 |
| Keywords | Agricultural Biotechnology, Environmental Sustainability, Forest Biotechnology |
| Founded | 1993 |
| Employees | 51-100 |
| Socials |
Key Contacts at FuturaGene
Lidor Gil
R&D Director, Tissue Culture And Greenhouse Operations
Dror Avisar
R&D Director, Yield Protection And Molecular Biology
FuturaGene Email Formats
FuturaGene uses 2 email formats. The most common is {first initial} (e.g., j@futuragene.com), used 56.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@futuragene.com | 56.7% |
{first name} | john@futuragene.com | 43.3% |
About FuturaGene
FuturaGene is a pioneer in the enhancement of yield and sustainability of woody crops for the plantation forestry industry. Our aim is to provide a better future for society by producing more wood using fewer natural resources. Through our expertise in plant genetic research and development, we develop technologies that are applicable to the renewable forestry, biofuels, biopower and biomaterials sectors. Our key crop is subtropical, renewable eucalyptus. With research centers in Brazil and Israel, FuturaGene focuses on two main technological platforms: yield enhancement, to meet growing wood demand, and yield protection, to protect plantation forests from increasing pest and disease threats, caused, inter alia, by climate change. FuturaGene is the first company in the world to have obtained regulatory approval to commercially deploy a yield-enhanced genetically modified eucalyptus variety. This achievement represents a key milestone in the recognition that biotechnology is a key tool for the sustainable intensification of renewable forests. FuturaGene is a wholly owned subsidiary of Suzano of Brazil, the world leader in the production of market pulp from renewable eucalyptus plantations.
FuturaGene revenue & valuation
| Annual revenue | $3,000,000 |
| Revenue per employee | $43,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $9,600,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
FuturaGene has 23 employees across 8 departments.
Departments
Number of employees
Funding Data
FuturaGene has never raised funding before.
FuturaGene Tech Stack
Discover the technologies and tools that power FuturaGene's digital infrastructure, from frameworks to analytics platforms.
Web servers
JavaScript libraries
Tag managers
PaaS
Programming languages
Blogs
UI frameworks
Analytics
Databases
JavaScript libraries
India
Australia
Germany
United States
France
IrelandFrequently asked questions
4.8
40,000 users
